Diana Caumol|
Anu Dhamecha joined the MJ team as the director of pharmacy practice within our Benefits Consulting department and brings over a decade of industry experience with her. In her role, Anu is responsible for providing strategic consulting and insights related to pharmacy benefits management (PBM), cost containment, and clinical strategies. She delivers a structured, data-driven, and outcomes-focused approach to pharmacy strategy, ensuring clients receive innovative, tailored solutions aligned with their business goals.
Prior to MJ, Anu served as a vice president of pharmacy solutions and clinical thought leader at one of the largest brokers in the world. In this role, she guided clients through the complexities of pharmacy benefits, creating innovative management strategies to address costs and improve patient outcomes. Her ability to think outside the box while still aligning the pharmacy program to each client’s unique business goals and objectives makes her an invaluable asset to the MJ team.
Related Blogs
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
DeAnn DeckThe Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
The Hard Market Is Shifting—Here’s What That Means for YOU
Adam AdlerFor years, organizations have been told the same thing at renewal: higher costs, fewer options, and little room to negotiate. Now, that message is ...
Read More
Employer Response to Pharma Shifts
Chris AntypasVolatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More
White House Launches TrumpRx, Unveils Drug Prices
DeAnn DeckOn Feb. 5, President Donald Trump announced the launch of TrumpRx.gov, a federally operated website to help individuals buy prescription medications at discounted cash ...
Read More
DOL Issues Updated Model Employer CHIP Notice
DeAnn DeckThe U.S. Department of Labor (DOL), through its Employee Benefits Security Administration (EBSA), has released a new model Employer CHIP Notice with information current ...
Read More
Prescription Drug Reporting (RxDC Report)
DeAnn DeckThe No Surprises Act (NSA), enacted as part of the Consolidated Appropriations Act, 2021 (CAA), includes transparency provisions requiring group health plans to report ...
Read More